Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
![]()
Reuters NewMedia, Inc. - Thursday December 12 11:10 AM EST
Paracelsian is seeking to market AndroVir, a herb-based product, as a dietary supplement for HIV-positive people.
The company said three of 16 people in the trial withdrew after experiencing a bitter taste and an allergic reaction. But there was a 38 percent median drop in HIV viral load of the 13 people who finished the trial, and a 31 percent median increase in CD4 cell counts, a measure of immune function, the company said.
The company said it will further test AndroVir to determine dosage regimens. The company said the product cost should be less than $1,000 a year, based on the dose ranges it is considering.
961212
RE961263
Copyright © 1996 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .